3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Solid Tumor
2
Neoplasms
2
Meningioma
2
Breast Neoplasms
2
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Neurofibromatosis 2
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Fallopian Tube Neoplasms
1
Estrogen Receptor Positive Breast Cancer
1
Endometrial Neoplasms
1
Disease
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Advanced Cancer
1
Adenocarcinoma
1
Interventions
Paclitaxel
42
Carboplatin
35
pembrolizumab
25
Surveys and Questionnaires
23
Letrozole
15
Radiotherapy
14
Megestrol Acetate
14
Blood Specimen Collection
14
Bevacizumab
13
olaparib
12
Metformin
12
dostarlimab
10
Indocyanine Green
10
durvalumab
9
Observation
9
Medroxyprogesterone Acetate
9
Cisplatin
9
lenvatinib
8
atezolizumab
8
Early Intervention, Educational
8
Counseling
8
niraparib
7
Sentinel Lymph Node Biopsy
7
Radiation
7
Methods
7
Magnetic Resonance Spectroscopy
7
Lymph Node Excision
7
Hysterectomy
7
Everolimus
7
abemaciclib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Endometrial Neoplasms
×
vistusertib
×
Clear all
NCT02730923
2024-02-13
VICTORIA
Centre Leon Berard
Phase 1/2
Unknown
72 enrolled